BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension

  • End date
    Dec 10, 2023
  • participants needed
  • sponsor
Updated on 4 October 2022
intraocular pressure


The purpose of this study is to evaluate the clinical efficacy of the BREMEN eye drops in the treatment of primary open-angle glaucoma or intraocular hypertension.

Condition Ocular Hypertension, Primary Open-angle Glaucoma
Treatment BREMEN eye drops, Combigan®
Clinical Study IdentifierNCT03235232
Last Modified on4 October 2022


Yes No Not Sure

Inclusion Criteria

Signed Consent
Participants with diagnosis of open-angle glaucoma or hypertension ocular, who needs treatment with drugs association to control the intraocular pressure
Participants who have 20/80 visual acuity or more, in both eyes

Exclusion Criteria

Participants with any clinical significant disease that, after evaluation of the investigator, can´t participate in the study
Participants with active eye disease, which in the investigator opinion may interfere in the results of this clinical trial
Participants presenting previous diagnosis of non-operated cataract, high myopia, high astigmatism, pseudoexfoliation and corneal deformities
Participants who had significant visual loss in the last year
Treatment-naive participants for open-angle glaucoma or ocular hypertension
Participants nonresponders to previous triple combination drug therapy, used in concomitance
Participants with previous ocular or intraocular surgery within six months prior to enrollment in the clinical trial
Participants with history of hypersensitivity to any formula compounds
Participants presenting contraindications to use of beta-adrenergic antagonists
Participants diagnosed with uncontrolled cardiovascular disease
Participants with severe renal insufficiency or hyperchloremic acidosis
Participants in therapy with monoamine oxidase inhibitors (MAOIs)
Participants who were in use of drugs that can interfere in the evaluation
Pregnancy or risk of pregnancy and lactating patients
Alcoholism or illicit drug abuse in the last two years
Participation in clinical trial in the year prior to this study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note